During the past decade, Medizentrum Essen Borbeck conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medizentrum Essen Borbeck" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Pfizer" with 2 trials sponsored, "Asarina Pharma" with 1 trials sponsored, "BioNTech SE" with 1 trials sponsored and "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medizentrum Essen Borbeck" #1 collaborator was "Biofortis Mérieux NutriSciences" with 1 trials as a collaborator, "Ergomed" with 1 trials as a collaborator, "FGK Clinical Research GmbH" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Medizentrum Essen Borbeck" are "Cardiovascular Disease" (2 trials), "Type 2 Diabetes" (2 trials), "Acute Cough" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Medizentrum Essen Borbeck" in a lesser frequency.

Most popular intervention types in "Medizentrum Essen Borbeck" are "Drug" (9 trials), "Biological" (3 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Tirzepatide" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Astegolimab" (1 trials) and "BNT162b1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medizentrum Essen Borbeck" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Medizentrum Essen Borbeck". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Medizentrum Essen Borbeck, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Medizentrum Essen Borbeck, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".